WATERTOWN, Mass.--(BUSINESS WIRE)--Dyno Therapeutics today announced a collaboration with NVIDIA to leverage Dyno’s field-leading artificial intelligence (AI) and in vivo experimentation capabilities, ...
The inaugural Genetic Agency Technology Conference (GATC) on November 11th, 2025 will convene technical thought leaders, gene therapy developers, patients, their families, and patient advocates across ...
Expanded Dyno Frontiers Program connects therapeutic developers to a marketplace of partners ready to manufacture Dyno capsids for preclinical studies, decreasing information asymmetry, de-risking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results